Enhanced white adipose tissue metabolism in iatrogenic Cushing's syndrome with FDG PET/CT
Related Experiment Video
Updated: May 3, 2026
![Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62460.jpg&w=3840&q=50)
08:31
Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
Published on: July 1, 2021
2.6K
David A Pattison1, Michael S Hofman, Eddie Lau
1Centre for Cancer Imaging (D.A.P., M.S.H., E.L., R.W., R.J.H.), and Endocrinology Service (D.A.P.), Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia; and Departments of Medicine (M.S.H., R.J.H.) and Radiology (E.L., R.J.H.), University of Melbourne, Melbourne, VIC 3010, Australia.
The Journal of Clinical Endocrinology and Metabolism
|February 18, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Cushing Syndrome I: Introduction
36
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
36
Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24

